CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,431 enrolled
Drug / intervention
QOL questionaireother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02925338
NCT02925338N/ACompleted

OBSERVATOIRE NATIONAL D'UTILISATION D'INFLECTRA™ EN VIE RÉELLE.

Pfizer·observational·Posted Oct 5, 2016·Updated Jan 25, 2023

In Brief

An observational study evaluating QOL questionaire for Crohn Disease and 4 related conditions. Completed, enrolled 1,431 participants across 67 sites.

Detailed Summary

National, prospective, multicentre observational study designed for eligible patients treated with Inflectra. Its objectives are to describe under real conditions of use, the profile of patients treated with Inflectra and the response to treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 5, 2016
Enrollment StartOct 19, 2016
Primary CompletionApr 12, 2021
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 9.7 years ago

Interventions

QOL questionaireother

Health assessment questionnaire disability index for rheumatoid polyarthritis questionnaire